8-K
filed May 25, 2023, 7:59 PM ET
ticker CLPT
CIK 0001285550
other material
confidence high
sentiment positive
materiality 0.60
ClearPoint Neuro shareholders approve reduction of authorized shares from 200M to 90M
ClearPoint Neuro, Inc.
- Authorized common stock reduced from 200M to 90M shares; 98.7% of votes cast in favor.
- All eight director nominees elected: Burnett, Fletcher, Fallon, Girin, Johnson, Klein, Liau, Richards.
- Cherry Bekaert LLP ratified as independent auditor for FY2023; advisory executive compensation approved.
- Broker non-votes of 4,856,372 occurred on director elections and executive compensation.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
ClearPoint Neuro, Inc.: Amendment to reduce authorized common shares from 200,000,000 to 90,000,000 (effective 2023-05-24).
- Change
- charter amendment
- Effective
- 2023-05-24
Exact text from the filing
the Company’s stockholders approved an amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to reduce the number of authorized shares of the Company’s common stock from two hundred million (200,000,000) shares to ninety million (90,000,000) shares.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Advisory approval of executive compensation.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
3. Advisory approval of executive compensation. The stockholders, on an advisory basis, approved the compensation of the Company’s executives. The votes were cast as follows: For Against Abstentions Broker Non-Votes 9,224,361 127,029 223,249 4,856,372
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation.
- Proposal
- charter amendment
- Outcome
- passed
Exact text from the filing
4. Approval of the Amendment to the Amended and Restated Certificate of Incorporation. The stockholders approved the amendment to the Company’s Amended and Restated Certificate of Incorporation. The votes were cast as follows: For Against Abstentions Broker Non-Votes 14,331,081 14,944 84,986 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Ratification of the appointment of Cherry Bekaert LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023 at the 2023-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-31
Exact text from the filing
2. Ratification of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The votes were cast as follows: For Against Abstentions Broker Non-Votes 14,419,693 3,150 8,168 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Election of eight directors to serve until the 2024 annual meeting of stockholders.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
1. Election of Directors. The following named persons were elected as directors of the Company to serve until the 2024 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal. The votes were cast as follows: Name For Withheld Broker Non-Votes Joseph M. Burnett 9,508,775 65,864 4,856,372 R. John Fletcher 8,847,706 726,933 4,856,372 Lynnette C. Fallon 8,767,508 807,131 4,856,372 Pascal E.R. Girin 8,847,611 727,028 4,856,372 B. Kristine Johnson 8,784,039 790,600 4,856,372 Matthew B. Klein 9,508,771 65,868 4,856,372 Linda M. Liau 9,504,476 70,163 4,856,372 Timothy T. Richards 8,848,151 726,488 4,856,372
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.